: A look at the "next target" for vaccine technology—developing therapeutic vaccines to treat various forms of cancer.

: Features on the first successes against Ebola and the ongoing search for an effective HIV vaccine .

Official digital versions and physical back issues are typically available through these platforms:

: An interview with Alain Fischer , President of the Vaccine Strategy Guidance Council, regarding the future of vaccination. Where to Access or Download

: In-depth analysis of how mRNA technology, accelerated by the pandemic, is being applied to other diseases.

The Pour la Science Hors-Série issue for November–December 2021 is , titled " La nouvelle révolution des vaccins " (The New Vaccine Revolution).

This special edition explores how the rapid success of COVID-19 vaccines revitalized the entire field of immunology and biotechnology. Key Features of Issue No. 113